Understanding the structure–property relationship of bispecific monoclonal antibodies with Fc site-specific substitutions

Development of novel bispecific antibody (bsAb) platforms offers unprecedented opportunities for a wide variety of therapeutic applications. However, the expression and manufacturing of bsAbs with desired structures can be challenging. Owing to the uniqueness of each bsAb platform, more comprehensiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Bo, Zhao, Yunlong, Adaniya, Stephanie, Fu, Yue, Moon, Youmi, Heftel, Justin, Chen, Shuzhen, Xiao, Hui, Li, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294755/
https://www.ncbi.nlm.nih.gov/pubmed/37357447
http://dx.doi.org/10.1080/19420862.2023.2228006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294755/
https://www.ncbi.nlm.nih.gov/pubmed/37357447
http://dx.doi.org/10.1080/19420862.2023.2228006

Ejemplares similares